✦ LIBER ✦

Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency

✍ Scribed by Dvorak, Christopher C.; Hassan, Amel; Slatter, Mary A.; Hönig, Manfred; Lankester, Arjan C.; Buckley, Rebecca H.; Pulsipher, Michael A.; Davis, Jeffrey H.; Güngör, Tayfun; Gabriel, Melissa; Bleesing, Jacob H.; Bunin, Nancy; Sedlacek, Petr; Connelly, James A.; Crawford, David F.; Notarangelo, Luigi D.; Pai, Sung-Yun; Hassid, Jake; Veys, Paul; Gennery, Andrew R.; Cowan, Morton J.

Book ID: 126548637
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 360 KB
Volume: 134
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2014.06.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of long-term outcomes after a

Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors

✍ Hows, J M; Passweg, J R; Tichelli, A; Locasciulli, A; Szydlo, R; Bacigalupo, A; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 170 KB

Is the Use of 9/10 HLA Unrelated Donors

Is the Use of 9/10 HLA Unrelated Donors Still Acceptable in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies? Comparison with Transplants from 10/10 HLA Unrelated Donors and Siblings

✍ M. Michallet; M. Sobh; S. Morisset; M. Detrait; H. Labussiere; N. Tedone; S. Duc 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Comparable Outcome of Alternative Donor

Comparable Outcome of Alternative Donor and Matched Sibling Donor Hematopoietic Stem Cell Transplant for Children with Acute Lymphoblastic Leukemia in First or Second Remission Using Alemtuzumab in a Myeloablative Conditioning Regimen

✍ Alana A. Kennedy-Nasser; Catherine M. Bollard; G. Doug Myers; Kathryn S. Leung; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Long-term outcomes of HLA-matched siblin

Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China

✍ Qi-fa Liu; Xiao-jun Xu; Yin-kui Chen; Jing Sun; Yu Zhang; Zhi-ping Fan; Dan Xu; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 318 KB

Stable long term engraftment and amelior

Stable long term engraftment and amelioration of clinical phenotype following hematopoietic stem cell transplantation from a matched sibling donor for sickle cell disease using a reduced intensity conditioning regimen

✍ L. Krishnamurti; C. Wu; S. Baker; A.M. Yeager; J.E. Wagner 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 60 KB